Coca-cola Icecek A.s. · BIST:CCOLA
Coca-cola Icecek A.s — H1 2007 Earnings Presentation
16 slides from Coca-cola Icecek A.s's earnings presentation, Aug 28, 2007
Slide 1: Results for the period ending June 30, 2007
Results for the period ending June 30, 2007 August 28th, 2007 İstanbul, Turkey
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation includes forward-looking statements including, but not limited to, statements regarding Coca-Cola İçecek’s (“CCI”) plans, objectives, expectations and intentions and other statements that are not historical facts. Forward-looking statements can generally
Slide 3: Healthy Growth in 1H2007
Healthy Growth in 1H2007 Turkey Volume International Volume Consolidated Volume (Unit cases in millions) (Unit cases in millions) (Unit cases in millions) 12.2% 9.1% 28.2% 220 180 45 180 160 35 160.0 174.5 194.2 217.9 34.1 43.7 140 140 25 100 1H06 1H07 1H06 1H07 1H06 1H07
Slide 4: Strong Growth in 1H2007: Net Sales
Strong Growth in 1H2007 Turkey Net Sales International Net Sales Consolidated Net Sales (CMB - YTL in millions) (CMB – US$ in millions) (CMB - YTL in millions) 760 13.7% 130 28.7% 900 700 15.8% 110 840 640 780 580 90 720 520 89.2 114.8 646.6 735.4 70 769.8 891.6 460 660 400 50 600 1H06 1H07 1H06 1H0
Slide 5: Strong Growth in 1H2007: EBITDA
Strong Growth in 1H2007 Turkey EBITDA International EBITDA Consolidated EBITDA (CMB - YTL in millions) (CMB – US$ in millions) (CMB - YTL in millions) 22.3% 170 20 130 38.7% 19.0 26.5% 131.1 159.1 110 16 130 107.2 90 12 13.7 125.8 16.6% 17.8% 15.4% 16.6% 16.3% 17.8% 70 90 8 1H06 1H07 1H06 1H07 1H07
Slide 6: 2Q2007 Highlights
2Q2007 Highlights Turkey performing well Strong organic growth in Central Asia Iraq – Construction commenced Middle East making good progress
Slide 7: Turkey
Turkey Demand recovery started in 1Q, accelerated in 2Q Net sales revenue is above the volume increase due to the favorable impact of pricing, effective management of discounts and improvement in mix 1.5L PET packages for Coca-Cola, Fanta and Damla were introduced in the first quarter CCI continued
Slide 8: International Operations – Central Asia
International Operations – Central Asia Kazakhstan: New bottling capacity started in July Juice filling lines being installed Azerbaijan: Expanded branding activities, including shop signs placement, increased outdoor advertising and POP usage Additional filling and preform capacity added in July Ky
Slide 9: International Operations – Middle East
International Operations – Middle East Jordan: Continue to fine tune Business model Riwa, our water brand, performing as per plans Increasing numeric and weighted distribution Cooler Refurbishment Center is operational Iraq: Construction of new plant started Cooler placements continue Branding and s
Slide 10: Financial Review
Financial Review Burak Başarır CFO
Slide 11: Introduction to Financial Statements
Introduction to Financial Statements Basis of Preparation Consolidated / Turkey International YTL/$ Exchange Rates Functional Currency YTL USD June 30, 2007 1.3046 Reporting Currency YTL USD December 31, 2006 1.4056 Net Sales – Net of discounts and special consumption tax for Turkish operations Infl
Slide 12: Key Financials
Key Financials Financial Period Ending June 30th 2007 2006 ’07 vs. ‘06 (YTL in millions unless otherwise stated) Sales Volume (UC m) 217.9 194.2 12.2% Net Revenue 891.6 769.8 15.8% Gross Profit 365.7 248.9 46.9% Gross Profit Margin 41.0% 32.3% EBITDA 159.1 125.8 26.5% EBITDA Margin 17.8% 16.3% EBIT
Slide 13: Balance Sheet
Balance Sheet Financial Period Ending Financial Year Ending Financial Period Ending Financial Year Ending Assets June 30, 2007 December 31,2006 Liabilities andEquity June 30, 2007 December 31, 2006 124.0 50.9 340.6 214.1 (YTL in millions unless otherwise stated) Cash & cash equivalents Short-term de
Slide 14: 2007 Outlook
2007 Outlook Outlook EBITDA growth in excess of volume growth Management’s Focus Volume growth Revenue growth EBITDA margin CAPEX Capital spending is expected to be approximately 11% of revenues.
Slide 15: Closing Remarks
Closing Remarks
Slide 16: Q&A Session
Q&A Session